Pembro Before and After Melanoma Surgery Boosts Outcomes

Patients with advanced melanoma have better event-free survival if pembrolizumab is given both before and after surgery; the findings tally with the mechanism of action of the drug, say researchers.
Medscape Medical News

source https://www.medscape.com/viewarticle/988932?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost